Reassessment of inappropriate prescriptions of proton pump inhibitors in elderly in-patients: It's time to take action

Annales Pharmaceutiques Francaises - Tập 78 - Trang 150-157 - 2020
E. Nowbahari1,2, A. Bigot3, F. Maillot3,4, D. Antier1,4, L. Foucault-Fruchard1,4
1Department of pharmacy, Tours University Hospital, 37000 Tours, France
2Faculty of Pharmaceutical Sciences, Tours University, 37200 Tours, France
3Department of internal medicine, Tours University Hospital, 37000 Tours, France
4Inserm, UMR 1253, iBrain, Tours University, 37000 Tours, France

Tài liệu tham khảo

ANSM, 2014 Ameli, 2018 Base de données publique des médicaments. Résumé des caractéristiques du produit - INEXIUM 20mg, comprimé gastro-résistant - Base de données publique des médicaments, 2018, Ministère des solidarités et de la santé, France, http://base-donnees-publique.medicaments.gouv.fr/affichageDoc.php?specid=64578892&typedoc=R. Accessed 8 July 2018. Welage, 2005, Overview of pharmacologic agents for acid suppression in critically ill patients, Am J Health Syst Pharm, 62, S4, 10.1093/ajhp/62.10_Supplement_2.S4 Ksiądzyna, 2015, Overuse of proton pump inhibitors, Pol Arch Med Wewn, 125, 289 Janarthanan, 2012, Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis, Am J Gastroenterol, 107, 1001, 10.1038/ajg.2012.179 Jacob, 2016, The use of proton pump inhibitors is positively associated with osteoporosis in postmenopausal women in Germany, Climacteric, 19, 478, 10.1080/13697137.2016.1200549 Peyro Saint Paul, 2014, New frequent adverse reaction of PPI in older adults: mild hyponatremia, Therapie, 69, 157 Cundy, 2011, Proton pump inhibitors and severe hypomagnesaemia, Curr Opin Gastroenterol, 27, 180, 10.1097/MOG.0b013e32833ff5d6 Lambert, 2015, Risk of community-acquired pneumonia with outpatient proton-pump inhibitor therapy: a systematic review and meta-analysis, PLoS One, 10, e0128004, 10.1371/journal.pone.0128004 Yang, 2015, Proton-pump inhibitors use, and risk of acute kidney injury: a meta-analysis of observational studies, CMAJ Open, 3, E166, 10.9778/cmajo.20140074 Fossmark, 2005, Rebound acid hypersecretion after long-term inhibition of gastric acid secretion, Aliment Pharmacol Ther, 21, 149, 10.1111/j.1365-2036.2004.02271.x Vaduganathan, 2015, Revisiting the Clopidogrel–Proton pump inhibitor interaction: from bench to bedside, Circ Cardiovasc Interv, 8, e003208, 10.1161/CIRCINTERVENTIONS.115.003208 Pezalla, 2008, Initial assessment of clinical impact of a drug interaction between clopidogrel and proton pump inhibitors, J Am Coll Cardiol, 52, 1038, 10.1016/j.jacc.2008.05.053 Gilard, 2006, Influence of omeprazole on the antiplatelet action of clopidogrel associated to aspirin, J Thromb Haemost, 4, 2508, 10.1111/j.1538-7836.2006.02162.x Gjestad, 2015, Effect of proton pump inhibitors on the serum concentrations of the selective serotonin reuptake inhibitors citalopram, escitalopram, and sertraline, Ther Drug Monit, 37, 90, 10.1097/FTD.0000000000000101 Bon usage du médicament, 2009 Proton Pump Inhibitors: Use in Adults, 2013 Forgacs, 2008, Overprescribing proton pump inhibitors, BMJ, 336, 2, 10.1136/bmj.39406.449456.BE Parente, 2003, Hospital use of acid-suppressive medications and its fall-out on prescribing in general practice: a 1-month survey, Aliment Pharmacol Ther, 17, 1503, 10.1046/j.1365-2036.2003.01600.x Niklasson, 2003, Overuse of acid suppressive therapy in hospitalised patients with pulmonary diseases, Respir Med, 97, 1143, 10.1016/S0954-6111(03)00187-2 Zink, 2005, Long-term use of acid suppression started inappropriately during hospitalization, Aliment Pharmacol Ther, 21, 1203, 10.1111/j.1365-2036.2005.02454.x Thomas, 2010, Longitudinal analysis of the costs associated with inpatient initiation and subsequent outpatient continuation of proton pump inhibitor therapy for stress ulcer prophylaxis in a large managed care organization, J Manag Care Pharm, 16, 122, 10.18553/jmcp.2010.16.2.122 Ramirez, 2010, Overuse of PPIs in patients at admission, during treatment, and at discharge in a tertiary Spanish hospital, Curr Clin Pharmacol, 5, 288, 10.2174/157488410793352067 Farrell, 2017, Deprescribing proton pump inhibitors: evidence-based clinical practice guideline, Can Fam Physician, 63, 354 Thomson, 2010, Safety of the long-term use of proton pump inhibitors, World J Gastroenterol, 16, 2323, 10.3748/wjg.v16.i19.2323 Brunner, 2012, Long-term, open-label trial: safety and efficacy of continuous maintenance treatment with pantoprazole for up to 15 years in severe acid-peptic disease, Aliment Pharmacol Ther, 36, 37, 10.1111/j.1365-2036.2012.05106.x Schonheit, 2016, Appropriate proton pump inhibitors use in elderly outpatients according to recommendations, Geriatr Psychol Neuropsychiatr Vieil, 14, 383 Dipanda, 2017, Evaluation of the prescription of proton pump inhibitors in persons aged 75 years and older in a geriatric acute-care unit, Therapie, 72, 669, 10.1016/j.therap.2017.06.003 Wilsdon, 2017, Effectiveness of interventions to deprescribe inappropriate proton pump inhibitors in older adults, Drugs Aging, 34, 265, 10.1007/s40266-017-0442-1 Boghossian, 2017, Deprescribing versus continuation of chronic proton pump inhibitor use in adults, Cochrane Database Syst Rev, 3, CD011969